Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + methotrexate for clinically stable ectopic pregnancy
ACTRN12611001056987Phase 2Recruiting
- Sponsor
- Stephen Tong
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gefitinib and methotrexate in Ectopic pregnancy (EP), sponsored by Stephen Tong. Primary endpoint: Efficacy. Started Feb 2012; status: recruiting.
02
Drugs
gefitinibmethotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on ACTRN12611001056987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001056987.